Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2013, Article ID 612459, 4 pages
http://dx.doi.org/10.1155/2013/612459
Case Report

Lamotrigine Augmentation of Serotonin Reuptake Inhibitors in Severe and Long-Term Treatment-Resistant Obsessive-Compulsive Disorder

1Department of Psychiatry, Complejo Hospitalario Universitario, 15701 Santiago de Compostela, Spain
2Servicio de Salud Mental y Asistencia a Drogodependencia Servicio Gallego de Salud, 15703 Santiago de Compostela, Spain
3Mental Health Research Center, Eastern State Hospital, Lexington, KY 40508, USA

Received 29 April 2013; Accepted 13 June 2013

Academic Editors: J. S. Brar, L. Dell'Osso, E. Jönsson, and D. L. Noordsy

Copyright © 2013 Manuel Arrojo-Romero et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Koran, G. L. Hanna, E. Hollander, G. Nestadt, and H. B. Simpson, “Practice guideline for the treatment of patients with obsessive-compulsive disorder,” The American Journal of Psychiatry, vol. 164, no. 7, supplement, pp. 5–53, 2007. View at Google Scholar · View at Scopus
  2. G. M. Soomro, D. Altman, S. Rajagopal, and M. Oakley-Browne, “Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD),” Cochrane Database of Systematic Reviews, no. 1, Article ID CD001765, 2008. View at Google Scholar · View at Scopus
  3. D. J. Stein, N. Koen, N. Fineberg et al., “A 2012 evidence-based algorithm for the pharmacotherapy for obsessive-compulsive disorder,” Current Psychiatry Reports, vol. 14, no. 3, pp. 211–219, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Komossa, A. M. Depping, M. Meyer, W. Kissling, and S. Leucht, “Second-generation antipsychotics for obsessive compulsive disorder,” Cochrane Database of Systematic Reviews, vol. 12, Article ID CD008141, 2010. View at Google Scholar · View at Scopus
  5. M. H. Bloch, J. McGuire, A. Landeros-Weisenberger, J. F. Leckman, and C. Pittenger, “Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder,” Molecular Psychiatry, vol. 15, no. 8, pp. 850–855, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Ipser, P. Carey, Y. Dhansay, N. Fakier, S. Seedat, and D. J. Stein, “Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD005473, 2006. View at Google Scholar · View at Scopus
  7. J. de Leon, A. Chambers, M. Hyatt et al., “A practitioner’s guide to prescribing lamotrigine for adults with intellectual disabilities,” in A Practitioner’s Guide for Prescribing Anticonvulsants and Mood Stabilizers for Adults with Intellectual Disabilities, J. de Leon, Ed., pp. 155–184, Springer, New York, NY, USA, 2012. View at Google Scholar
  8. M. Poyurovsky, I. Glick, and L. M. Koran, “Lamotrigine augmentation in schizophrenia and schizoaffective patients with obsessive-compulsive symptoms,” Journal of Psychopharmacology, vol. 24, no. 6, pp. 861–866, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. L. W. Bisol and D. R. Lara, “Improvement of obsessive-compulsive disorder with divalproex and lamotrigine in two patients with bipolar II disorder,” Pharmacopsychiatry, vol. 42, no. 1, pp. 37–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. C. Ramesh Kumar and S. Khanna, “Lamotrigine augmentation of serotonin re-uptake inhibitors in obsessive-compulsive disorder,” Australian and New Zealand Journal of Psychiatry, vol. 34, no. 3, pp. 527–528, 2000. View at Google Scholar · View at Scopus
  11. Ö. Uzun, “Lamotrigine as an augmentation agent in treatment-resistant-obsessive compulsive disorder: a case report,” Journal of Psychopharmacology, vol. 24, no. 3, pp. 425–427, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Bruno, U. Micò, G. Pandolfo et al., “Lamotrigine augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study,” Journal of Psychopharmacology, vol. 26, pp. 1456–1462, 2012. View at Google Scholar
  13. W. K. Goodman, L. H. Price, S. A. Rasmussen et al., “The Yale-Brown Obsessive Compulsive Scale. I. Development, use and reliability,” Archives of General Psychiatry, vol. 46, no. 11, pp. 1006–1011, 1989. View at Google Scholar · View at Scopus
  14. W. K. Goodman, L. H. Price, S. A. Rasmussen et al., “The Yale-Brown Obsessive Compulsive Scale. II. Validity,” Archives of General Psychiatry, vol. 46, no. 11, pp. 1012–1016, 1989. View at Google Scholar · View at Scopus
  15. C. Pittenger, M. H. Bloch, and K. Williams, “Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment,” Pharmacology and Therapeutics, vol. 132, no. 3, pp. 314–332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Wu, G. L. Hanna, D. R. Rosenberg, and P. D. Arnold, “The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder,” Pharmacology Biochemistry and Behavior, vol. 100, no. 4, pp. 726–735, 2012. View at Publisher · View at Google Scholar · View at Scopus